Affordable, high performance peptide synthesiser stars at 8th German Peptide Symposium

Activotec selected the recent 8th German Peptide Symposium in Heidelberg, Germany, to display its latest products and proprietary techniques for peptide synthesis.

Covering topics including peptides in cancer research & therapy, glycopeptides, peptide chemistry, pharmaceutical peptide manufacture and peptide / protein synthesis & engineering the symposium drew a large audience of researchers, about 40% of these coming from countries other than Germany.

Chris Littlewood, CEO of Activotec commented " Traffic to our exhibition stand was constant throughout the show. We were particularly pleased with the strong interest shown in our Activo-P11 Peptide Synthesiser and in our proprietary techniques in peptide backbone modification used to develop modified GLP-1 analogues".

The Activo-P11 Peptide Synthesiser is an easy to use and affordable instrument for synthesis of very high quality peptides. Designed and manufactured in Europe the fully automated and enclosed system performs a wide range of chemistries to synthesise peptides of any length in the 0.1 - 1.0 mmol. scale. Combined with very easy-to-use software, designed by chemists for chemists, the Activo-P11 was one of the most visited attractions at the exhibition.

Particular interest was also shown in a technical poster describing a study in which it Activotec had applied its proprietary technologies in peptide backbone modification to develop a set of modified GLP-1 analogues which have been stabilised against proteolysis, yet are at least as active as native GLP-1 in both promoting insulin release in cell assays and lowering blood glucose in small animal models. These exciting results drew considerable attention from biotech and pharmaceutical industry researchers involved in the diabetes therapeutic area.

Activotec, which has its trading base in Cambridge (UK) and an R&D and production facility in Southampton (UK), was founded in 2002 as a spin out from the internationally renowned School of Biological Sciences at the University of Southampton. Activotec is a customer-focused company providing high technology products and services for chemistry and biochemistry applications. Activotec provides a complete range of products and services for peptide and protein synthesis.

For further information on the Activo-P11 peptide synthesiser or peptide backbone modification to develop modified GLP-1 analogues please contact Activotec.